Table 3.
Characteristics | Total (N) |
Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|---|
Hazard ratio (95% CI) | P value | Hazard ratio (95% CI) | P value | ||
Age (>60 VS <=60) | 549 | 1.847 (1.160-2.940) | 0.010 | 1.478 (0.841-2.596) | 0.175 |
Clinical stage (Stage IV&Stage III&Stage II VS Stage I) | 551 | 3.270 (2.145-4.984) | <0.001 | 2.770 (1.622-4.730) | <0.001 |
Histologic grade (G3 VS G2&G1) | 540 | 3.281 (1.907-5.643) | <0.001 | 1.924 (1.016-3.644) | 0.045 |
Tumor invasion(%)(>=50 VS <50) | 473 | 2.813 (1.744-4.535) | <0.001 | 1.792 (1.058-3.034) | 0.030 |
BMI(>30 VS <=30) | 518 | 1.034 (0.680-1.572) | 0.876 | ||
Menopause status (Peri&Post VS Pre) | 505 | 0.828 (0.382-1.794) | 0.632 | ||
Histological type (Endometrioid VS Serous & Mixed) | 551 | 0.380 (0.253-0.573) | <0.001 | 0.778 (0.438-1.379) | 0.390 |
S100A2 (High VS Low) | 551 | 1.616 (1.069-2.442) | 0.023 | 1.635 (1.005-2.659) | 0.048 |